Novel strategies for the treatment of small-cell lung carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2011.90.pdf
Reference121 articles.
1. Govindan, R. et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol. 24, 4539–4544 (2006).
2. Spiro, S. G. et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J. Clin. Oncol. 24, 3823–3830 (2006).
3. Fried, D. B. et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J. Clin. Oncol. 22, 4837–4845 (2004).
4. De Ruysscher, D. et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J. Clin. Oncol. 24, 1057–1063 (2006).
5. Pijls-Johannesma, M. C., De Ruysscher, D., Lambin, P., Rutten, I. & Vansteenkiste, J. F. Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database of Systematic Reviews, Issue 4. Art.: CD004700. doi: 10.1002/14651858.CD004700.pub2 (2005).
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer;Frontiers in Pharmacology;2024-04-12
2. Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors;Science Advances;2024-01-19
3. The prognostic impact of a high number of peritumoral alveolar macrophages in neuroendocrine carcinoma in the lung;Pathology International;2023-08-17
4. DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2023-06
5. A review of recent advances in the novel therapeutic targets and immunotherapy for lung cancer;Medical Oncology;2023-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3